.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Ceres is stocked at 261 licensed dispensaries across Washington, with the deepest coverage in Seattle, Tacoma, Spokane, Vancouver, and Olympia. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Ceres concentrated 54.16% of sales in Topical with year-over-year down 1.47% and month-over-month down 7.24%, while Edible held 39.52% share with year-over-year down 4.47% but month-over-month up 6.23%. Capsules remained a small 3.14% share yet rose 13.43% month-over-month against a 0.85% year-over-year decline, and Tincture & Sublingual slipped to 2.70% share with year-over-year down 34.53% and month-over-month down 14.11%. Vapor Pens, though only 0.38% share, spiked 185.55% month-over-month and 79.39% year-over-year, while Concentrates at 0.10% share fell 14.22% month-over-month with no year-over-year basis. The mix shift shows stabilization around Topical and Edible with tactical experimentation in smaller formats, implying a cautious pivot toward faster-cycling form factors despite overall brand sales year-over-year down 3.70% and average price up 2.14%.
These shifts imply Ceres is defending its lead in Washington Topical where it ranked 1 while using Capsules’ 13.43% month-over-month growth and Vapor Pens’ 185.55% month-over-month surge to probe adjacency demand, even as Edible’s 6.23% month-over-month gain must offset Topical’s 7.24% month-over-month pullback. The 34.53% year-over-year contraction in Tincture & Sublingual alongside an average price increase of 2.14% and brand sales year-over-year down 3.70% suggests price-taking power is concentrated in Topical, pushing the brand to balance mix by leaning into momentum pockets without diluting its category anchor; the pattern implies prioritizing Topical leadership while scaling Edible and selective micro-bets to stabilize the 24-month sales decline of 2.98%.
Competitive Landscape
Ceres holds rank #1 in WA Topical in September 2026 with no year-over-year rank change from #1, while its peak also sits at #1 in September 2026; in contrast, Agro Couture remains #2 with a 3.31% year-over-year sales lift and Double Delicious stays #3 despite a -40.44% year-over-year sales decline, and SnacMe advanced from #6 to #5 on 9.96% growth, indicating that Ceres’ unchanged #1 position against both negative (-40.44%) and modest positive (+3.31%, +9.96%) competitor momentum implies durable category leadership rather than a transient advantage.
Notable Products
The steepest decline came from CBD/THC/CBG/CBN 1:1 Xtra Strength Dragon Pain Relieving Squeeze Lotion (1000mg CBD, 1150mg THC, 75mg CBG, 75mg CBN, 3.4oz) at -10.9% MoM, slipping to rank 7 while the flagship CBD/THC/CBG/CBN 1:1 Xtra Strength Dragon Balm Roll on (1000mg CBD, 1150mg THC, 75mg CBG, 75mg CBN, 3.4oz, 100ml) held rank 1 at -5.9%, signaling pressure on the topical line despite leadership. In contrast, Sativa Assorted Fruit Chews 10-Pack (100mg) jumped 30.3% MoM to a shared rank 4 while the Sativa Sea Salted Caramel Chocolate Balls 10-Pack (100mg) rose 16.9% at rank 3, and four of the top ten are Edible SKUs, indicating mix shift toward ingestibles. The CBD/THC 1:1 Indica Assorted Fruit Chews 10-Pack (100mg CBD, 100mg THC) slipped -8.9% at rank 4 while CBD/THC 1:1 Sativa Assorted Fruit Chews 10-Pack (100mg CBD, 100mg THC) gained 8.1% at rank 5, pointing to Sativa-led momentum versus Indica within 1:1 formats. This pattern implies Ceres is tilting from high-THC topicals toward Sativa-forward edibles for September 2026 as growth concentrates in higher-ranked confection SKUs while topical softness consolidates below rank 5.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
